Skip to main content

Find Clinical Trials

Home
Conditions
Urinary Bladder, Neurogenic

Clinical trial condition

Urinary Bladder, Neurogenic

Explore clinical trials studying Urinary Bladder, Neurogenic. Study availability and eligibility vary by location and protocol.

139 public trials 24 recruiting studies

Refine in advanced search Browse all conditions

Urinary Bladder, Neurogenic trial results

Completed

Incidence of Urinary Tract Infection After Urodynamic Investigation

NCT01297647

Conditions: Central Nervous System Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +16 more
Locations: Spinal Cord Injury Center & Research, University of Zürich, Balgrist University Hospital Zurich, Canton of Zurich, Switzerland

View Trial Details

Completed

Neuro-urological Outcome After Spinal Cord Injury

NCT01297660

Conditions: Behavior, Central Nervous System Diseases, Female Urogenital Diseases, +19 more
Locations: Spinal Cord Injury Center & Research, University of Zürich, Balgrist University Hospital Zurich, Canton of Zurich, Switzerland

View Trial Details

Completed

Observational Study of Botulinum Toxin Type A in Patients With Urinary Incontinence Associated With Overactive Bladder

NCT02673047

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations: Site D'Aix En Provence Aix-en-Provence, France

CL Toulouse Lautrec Albi, France

CHU Angers Angers, France

CH Angouleme Angoulême, France

View all 50 locations

View Trial Details

Completed

A Biochip for Rapid Diagnosis of Complicated Urinary Tract Infection

NCT00591240

Conditions: Bladder, Neurogenic, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: VA Palo Alto Health Care System Palo Alto, California, United States

View Trial Details

Completed

Heart Rate Variability (HRV) in Patients With Neurogenic Detrusor Overactivity (NDO) Before and After Botulinum Neurotoxin Type A (BoNT/A) Intradetrusor Injections

NCT01337024

Conditions: Bladder Disorder, Neurogenic, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Spinal Cord Injury Center & Research, University of Zürich, Balgrist University Hospital Zurich, Canton of Zurich, Switzerland

View Trial Details

Completed

PK/PD, Long-term Safety and Efficacy of Tamsulosin Treatment in Children With Neurogenic Bladder

NCT00340704

Conditions: Bladder, Neurogenic, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Birmingham, Alabama, United States

Los Angeles, California, United States

Jacksonville, Florida, United States

Tampa, Florida, United States

View all 72 locations

View Trial Details

Completed

Effects of Antimuscarinics on Cognition in Spinal Cord Injury

NCT01600404

Conditions: Central Nervous System Diseases, Cognition Disorders, Cognitive Dysfunction, +21 more
Locations: Swiss Paraplegic Centre Nottwil, Canton of Lucerne, Switzerland

View Trial Details

Completed

Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder

NCT00796614

Conditions: Bladder, Neurogenic, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Los Angeles, California, United States

Tampa, Florida, United States

St Louis, Missouri, United States

Buffalo, New York, United States

View all 52 locations

View Trial Details

Completed

Multifaceted Treatment of Catheter-related Urinary Tract Infection

NCT00732238

Conditions: Central Nervous System Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +18 more
Locations: Michael E. DeBakey VA Medical Center (152) Houston, Texas, United States

View Trial Details

Completed

Alfuzosin Treatment in Children and Adolescents With Hydronephrosis of Neuropathic Etiology

NCT00576823

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hydronephrosis, +11 more
Locations: Sanofi-Aventis Administrative Office Sofia, Bulgaria

Sanofi-Aventis Administrative Office Laval, Canada

Sanofi-Aventis Administrative Office Tallinn, Estonia

Sanofi-Aventis Administrative Office Mumbai, India

View Trial Details